The 128 references in paper C. Ferri , С. Ферри (2010) “СМЕШАННАЯ КРИОГЛОБУЛИНЕМИЯ // MIXED CRYOGLOBULINEMIA” / spz:neicon:nefr:y:2010:i:1:p:11-28

1
Wintrobe M, Buell M. Hyperproteinemia associated with multiple myeloma. With report of a case in which an extraordinary hyperproteinemia was associated with trombosis of the retinal veins and symptoms suggesting Raynaud’s disease. Bull Johns Hopkins Hosp 1933; 52: 156-165
(check this in PDF content)
2
Lospalluto J, Dorward B, Miller W, Jr, Ziff M. Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin. Am J Med 1962; 32: 142-145
(check this in PDF content)
3
Ferri C, Zignego AL, Pileri SA. Cryoglobulins (review). J Clin Pathol 2002; 55: 4-13
(check this in PDF content)
4
Brouet JC, Clouvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. Am J Med 1974; 57:775-788
(check this in PDF content)
5
Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837-856
(check this in PDF content)
6
Gorevic PD, Kassab HJ, Levo X Kohn R, Meltzer M, Prose P, Franklin E. Mixed Cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287­ 308
(check this in PDF content)
7
Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C, Zanussi C. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol 1983; 70: 73-82
(check this in PDF content)
8
Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G, Candela M, Ferri C, Gabrielli A, Mazzaro C, Migliaresi S, Mussini C, Ossi E, Quintiliani L, Tirri G, Vacca A., GISC. Italian Group for the Study of Cryoglobulinaemias. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. QJM 1995; 88: 115-126
(check this in PDF content)
9
Dammacco F, Sansonno D. Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 1997; 15: 97-119
(check this in PDF content)
10
Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis (review). Arthritis Rheum 1999; 42: 2507-2516
(check this in PDF content)
11
Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA, Zignego AL. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007; 39: S13-21
(check this in PDF content)
12
Ferri C, Antonelli A, Mascia MT, Sebastiani S, Fallhai P, Ferrari D, Giunti M, Pileri SA, Zignego AL. B-cells and mixed cryoglobulinemia. Autoimmun Rev 2007; 7: 114-120
(check this in PDF content)
13
Mascia MT, Ferrari D, Campioli D, Sandri G, Mussini C, Ferri C. Non HCV-related mixed cryoglobulinemia. Dig Liver Dis 2007; 39: S61-64
(check this in PDF content)
14
Abel G, Zhang QX, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia (review). Arthritis Rheum 1993; 36: 1341-1349
(check this in PDF content)
15
Pawlotsky J, Mustapha B, Andre C, Voisin M-C, Intrator L, Roudot-Thoraval F, Deforges L, Duvoux C, Zairani E-S, Duval J. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841­ 848
(check this in PDF content)
16
Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300
(check this in PDF content)
17
Herrine SK. Approach to the patient with chronic hepatitis C virus infection. Ann Intern Med 2002; 136: 7477­ 7457
(check this in PDF content)
18
Ferri C, Bertozzi MA, Zignego AL. Erectile dysfunction and hepatitis C virus infection. JAMA 2002; 288: 698-699
(check this in PDF content)
19
Monteverde A, Ballarn M, Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Imunopathol 1997; 19: 99-110
(check this in PDF content)
20
Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M, Santini GF. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84: 3047-3053.
(check this in PDF content)
21
Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Baiocchi M, Dammacco F. Detection and distribution of hepatitis C-related proteins in lymph nodes of patients with type II cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996; 88: 4638-4645.
(check this in PDF content)
22
Dammacco F, Sansonno D, Piccoli C, Racanelli V, D’Amore FP, Lauletta G. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis 2000; 20: 143-157
(check this in PDF content)
23
Kallemuchikkal U, Gorevic PD. Evaluation of cryoglobulins. Arch Pathol Lab Med. 1999; 123: 119-125
(check this in PDF content)
24
Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL. Mixed cryoglobulinemia: demographic, clinical, and serological features, and survival in 231 patients. Sem Arthritis Rheum 2004; 33: 355-374
(check this in PDF content)
25
Ferri C, Mascia MT. Cryoglobulinemic vasculitis: Review. Curr Opin Rheumatol 2006; 18: 54-63
(check this in PDF content)
26
Bombardieri S, Ferri C, Migliorini P, Pontrandolfo A, Puccetti A, Vitali C, Pasero G. Cryoglobulins and immune complexes in essential mixed cryoglobulinemia. Ric Clin Lab 1986; 16: 281-288
(check this in PDF content)
27
Ferri C, Mannini L, Bartoli V, Gremignai G, Genovesi- Ebert F, Cristofani R, Albanese B, Pasero G, Bombardieri S. Blood viscosity and filtration abnormalities in mixed cryoglobulinemia patients. Clin Exp Rheumatol 1990; 8: 271­
(check this in PDF content)
28
28. Fadda P, La Civita L, Zignego AL, Ferri C. Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome. Reumatismo 2002; 54: 316-323
(check this in PDF content)
29
Ferri C, La Civita L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S, Rossi B. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiological investigations. J Rheumatol 1992; 19: 889-895
(check this in PDF content)
30
Ammendola A, Sampaolo S, Ambrosone L, Ammendola E, Ciccone G, Migliaresi S, Di lorio G. Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study. Muscle Nerve 2005; 31: 382-385
(check this in PDF content)
31
Di Lullo L, De Rosa FG, Coviello R, Sorgi ML, Coen G, Zorzin LR, Casato M. Interferon toxicity in hepatitis C virus- associated type II cryoglobulinemia. Clin Exp Rheumatol 1998; 16: 506
(check this in PDF content)
32
La Civita L, Zignego AL, Lombardini F, Monti M, Longombardo G, Pasero G, Ferri C. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J Rheumatol 1996; 23: 1641-1643
(check this in PDF content)
33
Lidove O, Cacoub P, Hausfater P, Wechsler B, Frances C, Leger JM, Piette JC. Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment. Gastroenterol Clin Biol 1999; 23: 403-406
(check this in PDF content)
34
Casato M, Saadoun D, Marchetti A, Limal N, Picq C, Pantano P, Galanaud D, Cianci R, Duhaut P, Piette JC, Fiorilli M, Cacoub P. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol 2005; 32: 484-488
(check this in PDF content)
35
Druet P, Letonturier P, Contet A, Mandet C. Cryoglobulinaemia in human renal diseases. A study of seventy- six cases. Clin Exp Immunol 1973; 15: 483-496
(check this in PDF content)
36
Longombardo G, Ferri C, Marchi S, Costa F, Lombardini F, Vacri L, Bombardieri S, Migliorini P Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders. Clin Immunol Immunopathol 1998; 87: 124-129
(check this in PDF content)
37
Uchiyama-Tanaka X Mori X Kishimoto N, Nose A, Kijima X Nagata T, Umeda X Masaki H, Matsubara H, Iwasaka T. Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol 2004; 61: 144-150
(check this in PDF content)
38
Sabbatini A, Dolcher MP, Marchini B, Chimenti D, Moscato S, Pratesi F, Bombardieri S, Migliorini P. Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol 1997; 15: 655­ 658
(check this in PDF content)
39
Quartuccio L, Fabris M, Salvin S, Isola M, Soldano F, Falleti E, Beltrami CA, De Re V, De Vita S. Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis. Rheumatology (Oxford) 2007; 46: 1657-1661
(check this in PDF content)
40
Kaplanski G, Maisonobe T, Marin V, Grns S, Robitail S, Farnarier C, H ar^ JR, Piette JC, Cacoub P Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C- associated mixed cryoglobulinemia. J Hepatol.2005; 42: 334­ 340
(check this in PDF content)
41
Bombardieri S, Paoletti P, Ferri C, Di Munno O, Fornai E, Giuntini C. Lung involvement in essential mixed cryoglobulinemia. Am J Med 1979; 66: 748-756
(check this in PDF content)
42
Salaffi F, Manganelli P, Carotti M, Subiaco S, Cervini C. Mixed cryoglobulinemia: effect of alpha-interferon on subclinical lymphocytes alveolitis. Clin Exp Rheumatol 1996; 14: 219-220
(check this in PDF content)
43
Ferri C, La Civita L, Fazzi P, Solfanelli S, Lombardini F, Begliomini N, Monti M, Longombardo G, Pasero G, Zignego AL. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol 1997; 36: 360­ 365
(check this in PDF content)
44
Manganelli P, Salaffi F, Subiaco S, Carotti M, Cervini C, Consigli G, Majori M, Pesci A. Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus. B r J Rheumatol 1996; 35: 978-982
(check this in PDF content)
45
Vitali C, Ferri C, Nasti P, La Civita L, Mazzantini M, Longombardo G, Bombardieri S. Hypercomplementaemia as a marker of the evolution from benign to malignant B-cell proliferation in patients with type II mixed cryoglobulinaemia. Br J Rheumatol 1994; 33: 791-792
(check this in PDF content)
46
Antonelli A, Ferri C, Fallahi P, Giuggioli D, Nesti C, Longombardo G, Fadda P, Pampana A, Maccheroni M, Ferrannini E. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 2004; 97: 499-506
(check this in PDF content)
47
Antonelli A, Ferri C, Fallahi P, Sebastiani M, Nesti C, Barani L, Barale R, Ferrannini E. Type 2 diabetes in hepatitis C- related mixed cryoglobulinaemia patients. R heum atology (Oxford) 2004; 43: 238-240
(check this in PDF content)
48
Antonelli A, Ferri C, Fallahi P, Nesti C, Zignego AL, Maccheroni M. Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin Exp Rheumatol 2002; 20: 693­ 696
(check this in PDF content)
49
Ferri C, Bertozzi MA, Zignego AL. Erectile dysfunction and hepatitis C virus infection. JAMA 2002; 288: 698-699
(check this in PDF content)
50
Antonelli A, Ferri C, Fallahi P Thyroid cancer in patients with hepatitis C infection. JAMA 1999; 281: 1588
(check this in PDF content)
51
Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R, Liberati AM, Gerli R, Greco F, Moretti A, Monti M, Gentilini P, Bombardieri S, Zignego AL. Alpha- Interferon in Mixed Cryoglobulinemia patients: a randomized crossover controlled trial. Blood 1993; 81: 1132-1136
(check this in PDF content)
52
Di Lullo L, De Rosa FG, Coviello R, Sorgi ML, Coen G, Zorzin LR, Casato M. Interferon toxicity in hepatitis C virus- associated type II cryoglobulinemia. Clin Exp Rheumatol 1998; 16: 506
(check this in PDF content)
53
La Civita L, Zignego AL, Lombardini F, Monti M, Longombardo G, Pasero G, Ferri C. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J Rheumatol 1996; 23: 1641-1643
(check this in PDF content)
54
Lidove O, Cacoub P, Hausfater P, Wechsler B, Frances C, Leger JM, Piette JC. Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment. Gastroenterol Clin Biol 1999; 23: 403-406
(check this in PDF content)
55
Antonelli A, Ferri C, Fallahi P, Sebastiani M, Nesti C, Barani L, Barale R, Ferrannini E. Type 2 diabetes in hepatitis C- related mixed cryoglobulinaemia patients. R heum atology (Oxford) 2004; 43: 238-240
(check this in PDF content)
56
Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-599
(check this in PDF content)
57
Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, Menegatti E, Olivieri I, Puoti M, Palazzi C, Roccatello D, Vergani D, Sarzi-Puttini P, Atzeni F. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 2008; 26: S39-S47
(check this in PDF content)
58
Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P, Gobbi M, Falini B, Bordin G, Pileri S. mixed cryoglobulinemia, type II: a manifestation of low malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988; 79: 20-25
(check this in PDF content)
59
Ferri C, Pileri S, Zignego AL. Hepatitis C virus, B-cell disorders, and non-Hodgkin’s lymphoma. In: Goedert JJ, editor. Infectious causes of cancer: targets for intervention National Cancer Institute (NIH). Totowa, NJ: The Humana Press Inc, 2000; 349-368
(check this in PDF content)
60
Pozzato G, Mazzaro C, Crovatto , Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M, Santini GF. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84: 3047-3053
(check this in PDF content)
61
La Civita L, Zignego AL, Monti M, Longombardo G, Pasero G, Ferri C. Mixed cryoglobulinemia as a possible preneoplastic disorder. Arthritis Rheum 1995; 38: 1859-1860
(check this in PDF content)
62
Monti G, Pioltelli P, Saccardo F, Campanini M, Candela M, Cavallero G, De Vita S, Ferri C, Mazzaro C, Migliaresi S, Ossi E, Pietrogrande M, Gabrielli A, Galli M, Invernizzi F. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005; 165: 101-105
(check this in PDF content)
63
Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, Marrocchi EM, Di Pietro E, La Villa G, Laffi G, Gentilini P. Prevalence of BCL-2 rearrangement in hepatitis C virus- related mixed cryoglobulinemia with or without complicating B-cell lymphoma. Ann Intern Med 2002; 137: 571-580
(check this in PDF content)
64
Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A, Mazzaro C, Pasero G. Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. B r J Haematol 1994; 88: 392­ 394
(check this in PDF content)
65
Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin’s lymphoma: a meta-analysis of epidemiological studies. Cancer Sci. 2004; 95: 745-752
(check this in PDF content)
66
Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977; 296: 1501-1504
(check this in PDF content)
67
Choo GL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood- borne non- A non-B viral hepatitis genome. Science 1989; 244: 359-361
(check this in PDF content)
68
Pascual M, Perrin L, Giostra E, Schifer JA. Hepatitis C virus in patients with Cryoglobulinemia type II. J Infect Dis 1990; 162: 569-570
(check this in PDF content)
69
Ferri C, Marzo E, Longombardo G, Lombardini F, Greco F, Bombardieri S. Alpha-interferon in the treatment of mixed cryoglobulinemia patients. International Cancer Update. Focus on Interferon Alfa 2b. Cannes, France. November 1-4, 1990. Proceedings. Eur J Cancer 1991; 27: 81-82
(check this in PDF content)
70
Ferri C, Greco F, Longombardo G, Palla P, Marzo E, Moretti A, Mazzoni A, Pasero G, Bombardieri S, Highfield P, Corbishley T. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumato. 1991; 9: 621-624
(check this in PDF content)
71
Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E, Scudeller G. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-577
(check this in PDF content)
72
Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495
(check this in PDF content)
73
Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-3704
(check this in PDF content)
74
Gumber S, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations (review). Ann Intern Med 1995; 123: 615-620
(check this in PDF content)
75
Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V, Santini G, Crovatto M, Gloghini A, Dammacco F, Boiocchi M. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 86: 1887-1892
(check this in PDF content)
76
Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40: 2007-2015
(check this in PDF content)
77
Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brnchot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol1992; 15: 382-386
(check this in PDF content)
78
Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-941
(check this in PDF content)
79
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB., for the Italian Association of the Study of Liver Commission on Extrahepatic Manifestations of HCV infection. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach: Review. Dig Liver Dis 2007; 39: 2-17
(check this in PDF content)
80
Sansonno D, Tucci FA, De Re V, Lauletta G, Montrone M, Libra M, Dammacco F. HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation. Hepatology 2005; 42: 1019-1027.
(check this in PDF content)
81
Giannini C, Giannelli F, Zignego AL. Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology 2005; 42: 1019-1027
(check this in PDF content)
82
Machida K, Cheng KT, Sung VM, Shimodaira S, Lindsay KL, Levine AM, Lai MY, Lai MM. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 2004; 101: 4262­ 4267
(check this in PDF content)
83
Migliaresi S, Bresciani A, Ambrosone L, Spera M, Barbarulo D, Lombari V, Pirozzi G, Borgia G, Lombardi ML, Tirri G, Manzo C. Increased serum concentrations of soluble HLA- class I antigens in hepatitis C virus related mixed cryoglobulinaemia. Ann Rheum Dis 2000; 59: 20-25
(check this in PDF content)
84
Re V, Caggiari L, Simula MP, De Vita S, Mazzaro C, Lenzi M, Massimo GM, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Tirelli U, Cannizzaro R, Dolcetti R. Role of the HLA class II: HCV-related disorders. Ann N Y Acad Sci 2007; 1107: 308-318
(check this in PDF content)
85
Dimitrakopoulos AN, Kordossis T, Hatzakis A, Moutsopoulos HM. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 1999; 130: 226-230
(check this in PDF content)
86
Scotto G, Cibelli DC, Saracino A, Prato R, Palumbo E, Fazio V, Scarabaggio T, Monno L, Angarano G. Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/ HIV coinfection. J Infect 2006; 52: 294-299
(check this in PDF content)
87
Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjцgren’s syndrome. Arthritis Rheum 1996; 39: 767-772
(check this in PDF content)
88
Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277­ 280
(check this in PDF content)
89
Ferri C, Longombardo G, La Civita L, Greco F, Lombardini F, Cecchetti R, Cagianelli MA, Marchi S, Monti M, Zignego AL, Manns MP. Hepatitis C virus as common cause of mixed cryoglobulinemia and chronic liver disease. J Intern Med 1994; 236: 31-36
(check this in PDF content)
90
Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol 2000; 12: 295-299
(check this in PDF content)
91
Wener MH, Hutchinson K, Morishima C, Gretch DR. Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis-Rheum 2004; 50: 2305-2308
(check this in PDF content)
92
Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, Paoletti V, Valesini G. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004; 6: 137-141
(check this in PDF content)
93
Ramos-Casals M, GarcHa-Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G, S6nchez-Tapias JM, Font J, Ingelmo M. Hepatitis c virus infection mimicking primary Sjogren’s syndrome: a clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001; 80: 1-8
(check this in PDF content)
94
Vasil’ev VI, Probatova NA, Varlamova EIu, Tupitsin NN, Simonova MV, Safonova TN, Bozh’eva LA, Shornikova NS, Logvinenko OA, Belenin GIu. Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren’s disease. Ter Arkh 2004; 76: 61-68
(check this in PDF content)
95
Ramos-Casals M, De Vita S, Tzioufas A. Hepatitis C virus, Sjogren’s syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 2005; 4: 8­ 15
(check this in PDF content)
96
Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, Medina F, Rosas J, Anaya JM, Font J., SS-HCV Study Group. Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine 2005; 84: 81-89
(check this in PDF content)
97
Ramos-Casals M, Brito-Zeryn P, Yagbe J, Akasbi M, Bautista R, Ruano M, Claver G, Gil V, Font J. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren’s syndrome. Rheumatology (Oxford) 2005; 44: 89-94
(check this in PDF content)
98
loannidis JPA, Vassiliou VA, Moutsopoulos HM. Long term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjцgren’s syndrome. Arth Rheum 2002; 46: 741-747
(check this in PDF content)
99
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox Rl, Kassan SS, Pillemer SR, Talal N, Weisman MH., European Study Group on Classification Criteria for S j^ re n ’s Syndrome. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558
(check this in PDF content)
100
Pillemer SR, Smith J, Fox P, Bowman SJ. Outcome measures for Sjogren’s syndrome, april 10-11,2003, Bethesda, Maryland, USA. J Rheumatol 2005; 31: 143-149
(check this in PDF content)
101
Italian Group for the Study of Cryoglobulinemias (GISC). Ferri C., Ed. Metodologie di studio e protocolli diagnostici. S Margherita di Pula, Cagliari. 1989.
(check this in PDF content)
102
Tissot JD, Schifferli JA, Hochstrasser DF, Pasquali C, Spertini F, Clement F, Frutiger S, Paquet N, Hughes GJ, Schneider P. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. J Immunol Methods 1994; 173: 63-75
(check this in PDF content)
103
Andre M, Mahammedi H, Aumaitre O, Tridon A, Tissot JD, Piette JC. A «missed» cryoglobulin: the importance of in vitro calcium concentration. Ann Rheum Dis 2000; 59: 490-492
(check this in PDF content)
104
Mondelli MU, Zorzoli I, Cerino A, Cividini A, Bissolati M, Segagni L, Perfetti V, Anesi E, Garini P, Merlini G. Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications. J Hepatol 1998; 29: 879-886
(check this in PDF content)
105
Landau D, Saadoun D, Halfon F, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P. Relapse of Hepatitis C Virus- Associated Mixed Cr yoglobulinemia Vasculitis in Patients With Sustained Viral Response. Arthritis Rheum 2008; 58: 604-611
(check this in PDF content)
106
Casato M, Lagana B, Antonelli G, Dianzani F, Bonomo L. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood 1991; 78: 3142-3785
(check this in PDF content)
107
Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-756
(check this in PDF content)
108
Vassilopoulos D, Calabrese LH. Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 2002; 46: 585­ 597
(check this in PDF content)
109
Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to a- interferon therapy. Cancer 1996; 77: 2604-2613
(check this in PDF content)
110
Misiani R, Bellavita P, Baio P, Caldara R, Ferruzzi S, Rossi P, Tengattini F. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin. Nephrol Dial Transplant 1999; 14: 1558-1560
(check this in PDF content)
111
Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, Sabo E, Tsykounov I, Naschitz JE, Yeshurun D. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 2000; 27: 2172-2178
(check this in PDF content)
112
McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339: 1485-1492
(check this in PDF content)
113
Mazzaro C, Zora F, Caizzi M, Donada C, Di Gennaro G, Dal Maso K, Carniello G, Virgolini L, Tirelli U, Pozzato G. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 2005; 42: 632-638
(check this in PDF content)
114
Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P. Antiviral therapy for hepatitis C virus - associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum 2006; 54: 3696-3706
(check this in PDF content)
115
Barth H, Schnober EK, Neumann-Haefelin C, Thumann C, Zeisel MB, Diepolder HM, Hu Z, Liang TJ, Blum HE, Thimme R, Lambotin M, Baumert TF. Scavenger Receptor Class B is Required for Hepatitis C Virus Uptake and Cross-presentation by Human Dendritic Cells. J Virol 2008; 82: 3466-3479
(check this in PDF content)
116
Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D, De Marchi G, Michelutti A, Baccarani M, Fanin R, Ferraccioli G. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003; 101: 3827-3834
(check this in PDF content)
117
Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti- CD20. Blood 2003; 101: 3818-3126
(check this in PDF content)
118
Roccatello D, Baldovino S, Rossi D, Mansouri M, Naretto C, Gennaro M, Cavallo R, Alpa M, Costanzo P, Giachino O, Mazzucco G, Sena LM. Long-term effects of anti-CD20 monoclonal antibody treatm ent of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 2004; 19: 3054­ 3061
(check this in PDF content)
119
Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand? Ann Rheum Dis 2008; 67: 283-287
(check this in PDF content)
120
Ferri C, Moriconi L, Gremignai G, Migliorini P, Paleologo G, Fosella PV, Bombardieri S. Treatment of renal involvement in essential mixed cryoglobulinemia with prolonged plasma exchance. Nephron 1986; 43:246-251
(check this in PDF content)
121
Moriconi L, Ferri C, Puccini R, Casto G, Baronti R, Cecchetti R, Gremignai G, Cioni L, Bombardieri S. Double filtration plasmapheresis in the treatment of cryoglobulinemic glomerulonephritis. Int J Art Org 1989; 12: 83-86
(check this in PDF content)
122
Ferri C, Pietrogrande M, Cecchetti C, Tavoni A, Cefalo A, Buzzetti G, Vitali C, Bombardieri S. Low-antigen-content diet in the treatment of mixed cryoglobulinemia patients. Am J Med 1989; 87: 519-524
(check this in PDF content)
123
Ferri C, Puccini R, Longombardo G, Paleologo G, Migliorini P, Moriconi L, Pasero G, Cioni L. Low-antigen-content diet in the treatment of patients with IgA nephropathy. Nephrol Dial Transplant 1993; 8: 1193-1198
(check this in PDF content)
124
Lamprecht P, Lerin-Lozano C, Merz H, Dennin RH, Gause A, Voswinkel J, Peters SO, Gutzeit O, Arlt AC, Solbach W, Gross WL. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2003; 62: 1230­ 1233
(check this in PDF content)
125
Saadoun D, Resche-Rigon M, Sene D, Perard L, Piette JC, Cacoub P. Rituximab combined with Peg-Interferon- Ribavirin in refractory HCV-associated cryoglobulinemia vasculitis. Ann Rheum Dis 2008 Jan 4.
(check this in PDF content)
126
Galeazzi M, Bellisai F, Manganelli S, Morozzi G, Sebastiani GD. Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients. Autoimmun Rev 2006; 5: 493-498
(check this in PDF content)
127
Zein NN, for the Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol 2005; 42: 315-322
(check this in PDF content)
128
Vassilopoulos D, Calabrese LH. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections. Review. Curr Opin Rheumatol 2007; 19: 619-625 Перевод с английского: M.C. Храброва
(check this in PDF content)